Nasdaq
KTTA
Pasithea Therapeutics Corp.
- Health Care
- Listed 2021
- 1 day
- −1.4%
- 1 month
- −14.7%
- 1 year
- −35.2%
$0.4436 · Mkt cap $14.8M
At the 6 Aug 2026 close
Nasdaq
Pasithea Therapeutics Corp.
$0.4436 · Mkt cap $14.8M
At the 6 Aug 2026 close
Pasithea Therapeutics Corp. trades under the ticker KTTA on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2021. Its market capitalisation is $14.8M. The last closing price was $0.4436, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −35.2%, and −14.7% over the past month. Returns are price returns and exclude dividends.
This page exists because KTTA is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.